Clinical Trial Update: Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of capecitabine plus paclitaxel in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxol (paclitaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED